Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]. [PDF]
Brooks BR+5 more
europepmc +1 more source
CHANGES IN VITAL CAPACITY FOR SWIMMERS AND NORDIC SKIERS OVER 180 DAYS IN-SEASON TRAINING
Cheree Dean+5 more
openalex +1 more source
Lower Vital Capacity Is Associated With Diabetes but Not With Metabolic Syndrome in Nonobese Japanese Men [PDF]
Eiji Oda, Ryu Kawai
openalex +1 more source
This study presents an electronic fine‐tuning (EFT) strategy to optimize the electronic structures of Ru species and single‐atom Zn sites by the virtue of layered nanosheets, significantly enhancing ORR and HER activities. Spectroscopic analysis and theoretical calculations uncover that this EFT effect breaks the ORR scaling limitation and positions ...
Tingyu Lu+12 more
wiley +1 more source
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis [PDF]
Christopher Zappala+8 more
openalex +1 more source
In this article, a water‐evaporation driven energy harvester is devised that works even in the absence of sunlight. This is achieved by combining PVA hydrogel with thermoelectrics (TEG) to directly capture energy from water evaporation. Under mild conditions (RH 40%, T of 26 °C, and 2.8 m s−1 wind), 1.71 mW (1.02 W m−2) power can be generated, >3 fold ...
Zichen Gong, Ady Suwardi, Jing Cao
wiley +1 more source
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa. [PDF]
Boentert M+9 more
europepmc +1 more source
Improvements in the Ratio of Forced Expiratory Volume in One Second to Forced Vital Capacity in Asthmatic Children Receiving Inhaled Mometasone Furoate [PDF]
Henry Milgrom+2 more
openalex +1 more source
A multifunctional hydroxyapatite (HAp) coating integrated with silver‐gallium liquid metal nanoparticles (HAp‐Ag‐GaNPs) exhibits dual antibacterial and osteogenic properties. It effectively inhibits Gram‐positive and Gram‐negative bacteria, including resistant strains, while enhancing bone regeneration.
Ngoc Huu Nguyen+17 more
wiley +1 more source
Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry. [PDF]
Berger KI+11 more
europepmc +1 more source